FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
Position in JNJ — Johnson & Johnson
CIK 1009016
Cincinnati, OH
Position in JNJ
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$260,158,469
-$50,311,439 QoQ
Shares Held
1,064,304
-29.1% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87.37686858964719.ToString("F0")%
Shared 0.ToString("F0")%
None 12.623131410352814.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ holds $685,312,998 across 9 Drug Manufacturers - General names. JNJ ranks #1 (38.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,064,304 | $260,158,469 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
2,605,927 | $158,049,472 | |
| 3 | MRK |
Merck & Co., Inc.
|
659,851 | $79,373,476 | |
| 4 | PFE |
Pfizer Inc
|
2,042,039 | $57,340,455 | |
| 5 | LLY |
ELI LILLY & Co
|
52,225 | $48,034,988 | |
| 6 | ABBV |
AbbVie Inc.
|
207,858 | $45,207,035 | |
| 7 | AMGN |
Amgen Inc
|
92,090 | $32,401,865 | |
| 8 | NVS |
Novartis AG
|
29,042 | $4,436,165 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $260,158,469 | 1,064,304 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $310,469,908 | 1,500,217 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $276,265,231 | 1,489,943 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $227,557,479 | 1,489,738 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $246,970,254 | 1,489,208 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $246,226,251 | 1,702,574 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $264,959,186 | 1,634,945 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $241,534,369 | 1,652,534 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $268,380,566 | 1,696,571 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $270,742,017 | 1,727,332 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $268,677,316 | 1,725,055 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $292,960,634 | 1,769,941 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $272,846,810 | 1,760,302 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $309,464,125 | 1,751,849 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $286,881,233 | 1,756,129 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $325,844,101 | 1,835,638 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $338,057,895 | 1,907,453 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $325,600,952 | 1,903,320 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $315,691,640 | 1,954,747 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $213,961,181 | 1,298,781 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $214,706,346 | 1,306,397 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $201,929,241 | 1,283,068 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $214,021,104 | 1,437,541 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $201,125,510 | 1,430,175 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $183,755,091 | 1,401,320 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||